Australis Q3 2021 Conference Call

Rhea-AI Summary

Australis Capital Inc. hosted a conference call on March 2, 2021, to discuss its Q3 2021 financial results. During the call, the company outlined its acquisition strategy, including a 51% acquisition of ALPS and a potential full acquisition of Green Therapeutics LLC. These moves are part of AUSA's effort to establish itself as a competitive player in the U.S. and global cannabis markets. A recording will be available on the company's website.

Positive

• Acquisition strategy to enhance market position in the cannabis sector.
• 51% ownership acquisition of ALPS, a premier consultancy for horticultural crops.
• Plans to acquire 100% of Green Therapeutics LLC, an award-winning MSO.

Negative

• None.

Management Will Host Conference Call Tuesday March 2, 2021 at 10am ET

LAS VEGAS, March 2, 2021 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA" or the "Company") is hosting a conference call today at 10:00pm ET to discuss its Q3 2021 financial results (see press release March 1, 2021) as well as the go forward business.

Conference call details

Canada:	1.416.764.8659
North American Toll Free:	1.888.664.6392
Webcast URL:	https://bit.ly/37Rhatx
Confirmation #:	36589903
A replay of the call will be available until March 9, 2021. The replay can be accessed as follows:
Encore Replay Canada:		1.416.764.8677
Encore Replay North American Toll Free:		1.888.390.0541
Encore Replay Entry Code:		589903#

A recording of the call will be made available on the Company's website www.ausa-corp.com 

About AUSA

AUSA is implementing a growth strategy towards establishing a highly competitive and profitable MSO in the U.S. and global cannabis markets. AUSA is in the process of closing a transaction to acquire 51% ownership of ALPS, the world's premier design, construction management, commissioning and post commissioning consultancy for horticultural crops, such as cannabis, fruits, vegetables, mushrooms and algae. The Company will also hold an option for the acquisition of the remaining 49% of ALPS. AUSA is currently working towards the closing of a transaction whereby it will acquire 100% of the membership interest in Green Therapeutics LLC, an award-winning MSO with operations in Nevada, Missouri and Oklahoma. Through GT and ALPS, the Company believes it will be able to secure low-cost access to cannabis biomass to fuel the scale up of its award-winning brands across the U.S. and global cannabis markets. AUSA's other business and assets include investments in Cocoon, Body and Mind Inc., Quality Green, Folium Biosciences, and land assets in Washington and Michigan.

The Company's common shares trade on the CSE under the symbol "AUSA" and on the OTCQB under the symbol "AUSAF". 

View original content:http://www.prnewswire.com/news-releases/australis-q3-2021-conference-call-301238319.html

SOURCE Australis Capital Inc.

FAQ

When is the Australis Capital Inc. Q3 2021 earnings conference call?

The conference call is on March 2, 2021, at 10:00 PM ET.

What are the details of the acquisitions by Australis Capital Inc.?

Australis Capital is acquiring 51% of ALPS and plans to acquire 100% of Green Therapeutics LLC.

What is the ticker symbol for Australis Capital Inc. on the OTC market?

The ticker symbol for Australis Capital Inc. on the OTC market is AUSAF.

How can I access the recording of the Australis Capital conference call?

The recording can be accessed on the company's website after the call.

What is the focus of Australis Capital Inc.'s growth strategy?

The growth strategy focuses on establishing a competitive MSO in the U.S. and global cannabis markets.